Evidence map›Paper›PMID 23830731›Full record

ArticleCancer genetics2013

Integrated high-resolution array CGH and SKY analysis of homozygous deletions and other genomic alterations present in malignant mesothelioma cell lines.

Geula Klorin, Ester Rozenblum, Oleg Glebov, Robert L Walker, Yoonsoo Park, Paul S Meltzer, Ilan R Kirsch, Frederic J Kaye, Anna V Roschke

Abstract read
In one paragraph

Article in Cancer genetics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Trial
  2. Article
  3. DUSP7 inhibits cervical cancer progression by inactivating the RAS pathway.Journal of cellular and molecular medicine · 2021
    Article
  4. Article
  5. Article
  6. Fluorescence in situ hybridization (FISH) provides estimates of minute and interstitial BAP1, CDKN2A, and NF2 gene deletions in peritoneal mesothelioma.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2020
    Article
  7. Article
  8. Article
  9. Prevalent Homozygous Deletions of Type I Interferon and Defensin Genes in Human Cancers Associate with Immunotherapy Resistance.Clinical cancer research : an official journal of the American Association for Cancer Research · 2018
    Article
  10. Comparative Transcriptome Profiling Reveals Coding and Noncoding RNA Differences in NSCLC from African Americans and European Americans.Clinical cancer research : an official journal of the American Association for Cancer Research · 2017
    Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Geula KlorinGenetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Ester Rozenblum
Oleg Glebov
Robert L Walker
Yoonsoo Park
Paul S Meltzer
Ilan R Kirsch
Frederic J Kaye
Anna V Roschke
Center for Cancer Research · USNational Institutes of Health · USNational Cancer Institute · US

Funding

Cancer Genomics Technology DevelopmentZIABC011091 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI MELTZER, PAUL S. · 2009 to 2025
$16.9M
Molecular Cytogenetics CoreZICBC010930 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI ROSCHKE, ANNA · 2009 to 2014
$2.4M
Molecular Cytogenetics CoreZ01BC010930 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI ROSCHKE, ANNA · 2008 to 2008
$374k
Intramural NIH HHS Z01 BC010930Intramural NIH HHS Z99 CA999999Intramural NIH HHS ZIC BC010930
6 · The paper itself

Abstract

High-resolution oligonucleotide array comparative genomic hybridization (aCGH) and spectral karyotyping (SKY) were applied to a panel of malignant mesothelioma (MMt) cell lines. SKY has not been applied to MMt before, and complete karyotypes are reported based on the integration of SKY and aCGH results. A whole genome search for homozygous deletions (HDs) produced the largest set of recurrent and non-recurrent HDs for MMt (52 recurrent HDs in 10 genomic regions; 36 non-recurrent HDs). For the first time, LINGO2, RBFOX1/A2BP1, RPL29, DUSP7, and CCSER1/FAM190A were found to be homozygously deleted in MMt, and some of these genes could be new tumor suppressor genes for MMt. Integration of SKY and aCGH data allowed reconstruction of chromosomal rearrangements that led to the formation of HDs. Our data imply that only with acquisition of structural and/or numerical karyotypic instability can MMt cells attain a complete loss of tumor suppressor genes located in 9p21.3, which is the most frequently homozygously deleted region. Tetraploidization is a late event in the karyotypic progression of MMt cells, after HDs in the 9p21.3 region have already been acquired.

Indexed as

Gene DeletionCell Line, TumorChromosome AberrationsChromosomes, Human, Pair 9Comparative Genomic HybridizationHumansLung NeoplasmsMesotheliomaMesothelioma, MalignantSpectral Karyotypinghomozygous deletionsMalignant mesotheliomaoligonucleotide array CGHspectral karyotypingtumor suppressors

Identifiers

PMID23830731
PMCPMC4030604
OpenAlexW2100927245

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.